000274430 001__ 274430
000274430 005__ 20240229154934.0
000274430 0247_ $$2doi$$a10.1016/j.trecan.2023.03.001
000274430 0247_ $$2pmid$$apmid:36959035
000274430 0247_ $$2ISSN$$a2405-8033
000274430 0247_ $$2ISSN$$a2405-8025
000274430 0247_ $$2altmetric$$aaltmetric:144475803
000274430 037__ $$aDKFZ-2023-00594
000274430 041__ $$aEnglish
000274430 082__ $$a610
000274430 1001_ $$0P:(DE-He78)a2efd829a4ed4177427f4ceeafa06a3c$$aWinkelkotte, Alina$$b0$$eFirst author$$udkfz
000274430 245__ $$aPalmitate paves the way to lung metastasis.
000274430 260__ $$aAmsterdam$$bElsevier$$c2023
000274430 3367_ $$2DRIVER$$aarticle
000274430 3367_ $$2DataCite$$aOutput Types/Journal article
000274430 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1687856882_19597
000274430 3367_ $$2BibTeX$$aARTICLE
000274430 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000274430 3367_ $$00$$2EndNote$$aJournal Article
000274430 500__ $$a#EA:A410#LA:A410# / 2023 May;9(5):376-378 / Spotlight
000274430 520__ $$aNew findings by Altea-Manzano et al. demonstrate that primary breast tumours or a high-fat diet induce palmitate secretion by alveolar type 2 (AT2) cells to prepare a premetastatic niche that promotes lung metastasis. Palmitate is utilised by cancer cells via carnitine palmitoyltransferase 1a (CPT1a) and lysine acetyltransferase 2a (KAT2a) to acetylate nuclear factor-κB (NF-κB)/p65. Blocking these enzymes reduced metastasis formation in both lean and high-fat diet mice.
000274430 536__ $$0G:(DE-HGF)POF4-311$$a311 - Zellbiologie und Tumorbiologie (POF4-311)$$cPOF4-311$$fPOF IV$$x0
000274430 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000274430 650_7 $$2Other$$aNF-kB
000274430 650_7 $$2Other$$abreast cancer
000274430 650_7 $$2Other$$alung metastasis
000274430 650_7 $$2Other$$apalmitate
000274430 650_7 $$2Other$$apremetastatic niche
000274430 650_7 $$2Other$$aprotein acetylation
000274430 7001_ $$0P:(DE-He78)94ae391f53fb9285e1b68f9930615af1$$aSchulze, Almut$$b1$$eLast author$$udkfz
000274430 773__ $$0PERI:(DE-600)2852626-0$$a10.1016/j.trecan.2023.03.001$$gp. S2405803323000304$$n5$$p376-378 $$tTrends in cancer$$v9$$x2405-8033$$y2023
000274430 909CO $$ooai:inrepo02.dkfz.de:274430$$pVDB
000274430 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a2efd829a4ed4177427f4ceeafa06a3c$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000274430 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)94ae391f53fb9285e1b68f9930615af1$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000274430 9131_ $$0G:(DE-HGF)POF4-311$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vZellbiologie und Tumorbiologie$$x0
000274430 9141_ $$y2023
000274430 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-12
000274430 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-12
000274430 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bTRENDS CANCER : 2022$$d2023-08-25
000274430 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-08-25
000274430 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-08-25
000274430 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-08-25
000274430 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-08-25
000274430 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-08-25
000274430 915__ $$0StatID:(DE-HGF)9915$$2StatID$$aIF >= 15$$bTRENDS CANCER : 2022$$d2023-08-25
000274430 9202_ $$0I:(DE-He78)A410-20160331$$kA410$$lMetabolismus und Microenvironment$$x0
000274430 9201_ $$0I:(DE-He78)A410-20160331$$kA410$$lMetabolismus und Microenvironment$$x0
000274430 9200_ $$0I:(DE-He78)A410-20160331$$kA410$$lMetabolismus und Microenvironment$$x0
000274430 980__ $$ajournal
000274430 980__ $$aVDB
000274430 980__ $$aI:(DE-He78)A410-20160331
000274430 980__ $$aUNRESTRICTED